An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy

Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid Arthritis

NCT06108518 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain

NCT00881881 ·Status: COMPLETED

Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France

NCT02927535 ·Status: COMPLETED

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00565409 ·Status: COMPLETED ·Phase: PHASE4

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

NCT02804204 ·Status: UNKNOWN

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

NCT01646385 ·Status: COMPLETED

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

NCT00195377 ·Status: COMPLETED

Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

NCT00706797 ·Status: TERMINATED ·Phase: PHASE4

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

NCT00913458 ·Status: COMPLETED ·Phase: PHASE4

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572 ·Status: COMPLETED ·Phase: PHASE2

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use

NCT01083160 ·Status: TERMINATED

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

NCT00767325 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

Information and Acceptability of Biosimilars

NCT04321291 ·Status: UNKNOWN ·Phase: NA

Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis

NCT04117165 ·Status: WITHDRAWN ·Phase: NA

Very Early Versus Delayed Etanercept in Patients With RA

NCT02433184 ·Status: COMPLETED ·Phase: PHASE4

Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA

NCT00418717 ·Status: COMPLETED ·Phase: PHASE3

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

NCT02008266 ·Status: COMPLETED

Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis

NCT00321217 ·Status: UNKNOWN

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599 ·Status: COMPLETED ·Phase: PHASE2

COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

NCT03649061 ·Status: COMPLETED ·Phase: PHASE4

Rheumatoid Arthritis Synovial Tissue Biopsy Study

NCT07000890 ·Status: COMPLETED ·Phase: NA